This inventor holds 1 USPTO granted patent. Top assignee: Bayer Healthcare Aktiengesellschaft. Active years: 2006.
Company Filing History:
Years Active: 2006
Title: Alexander Vetter: Innovator in Imidazotriazinones
Introduction
Alexander Vetter is a notable inventor based in Cologne, Germany. He has made significant contributions to the field of chemistry, particularly in the production of specialized compounds. His work has led to the development of innovative methods that enhance the efficiency of chemical synthesis.
Latest Patents
Vetter holds a patent for a method for the production of 2-(2-ethoxyphenyl)-substituted imidazotriazinones. This invention involves a detailed process that includes the reaction of specific compounds and subsequent reactions with iodine or bromine, followed by a reaction with a metal cyanide and an acid. This patent showcases his expertise in chemical processes and his ability to innovate within the field.
Career Highlights
Alexander Vetter is currently employed at Bayer Healthcare Aktiengesellschaft, a leading company in the healthcare sector. His role at Bayer allows him to apply his inventive skills in a practical setting, contributing to advancements in healthcare solutions. Vetter's work is characterized by a commitment to innovation and excellence in research.
Collaborations
Vetter collaborates with Marc Nowakowski, a fellow professional in the field. Their partnership exemplifies the importance of teamwork in driving innovation and achieving successful outcomes in research and development.
Conclusion
Alexander Vetter is a distinguished inventor whose work in the production of imidazotriazinones has made a significant impact in the field of chemistry. His contributions continue to influence advancements in healthcare and chemical synthesis.